Genotyping heme oxygenase 1—the enzyme that catalyzes heme degradation—in patients, and measuring circulating TNF levels at diagnosis and after treatment, could be used to test the hypothesis that individual heme metabolism and TNF-associated inflammatory response may confer susceptibility to malaria-associated liver injury. Here, TNF is linked to malaria.